NCT01782261

Incretin Effect on the Immunological Phenotype

Pilot Study on Incretin Effect on the Immunological Phenotype in Healthy Subjects and in Type 1 Diabetic Subjects

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 15 (actual)
• Sponsor: Medical University of Graz · Academic / Other
• Sex: All
• Age: 18 Years – 50 Years
• Healthy volunteers: Accepted

Summary

Assessment of the effect of incretin based therapies (Liraglutide and Saxagliptin) on immune cells in healthy subjects and patients with type 1 diabetes

Detailed description

Assessment of immunological effects of Saxagliptin and Liraglutide on immune cells of the peripheral blood.

Conditions

• Type 1 Diabetes

Interventions

Type	Name	Description
DRUG	Liraglutide	once daily subcutaneous injection
DRUG	Saxagliptin	once daily tablet

Timeline

• Start date: 2012-02-01
• Primary completion: 2015-02-01
• Completion: 2015-02-01
• First posted: 2013-02-01
• Last updated: 2016-10-11

Locations

1 site across 1 country: Austria